Other Events ·
At its annual meeting on June 16, 2026, Dogwood Therapeutics, Inc. stockholders approved an amendment to the…
DWTXDogwood Therapeutics, Inc.
At its annual meeting on June 16, 2026, Dogwood Therapeutics, Inc. stockholders approved an amendment to the Certificate of Incorporation to increase the number of authorized shares of common and preferred stock. The meeting also resulted in the following voting results: election of seven directors, ratification of Forvis Mazars, LLP as independent auditor, and approval of advisory votes on executive compensation frequency and compensation. Dogwood Therapeutics, Inc. is a biotechnology company that develops therapeutic solutions for various medical conditions.